Nörogörüntüleme ile Migren Patofizyolojisinin Nörokimyasal ve Yapısal Özellikleri
Öz
Anahtar Kelimeler
Migren, Nörogörüntüleme, Migren Tedavisi, Manyetik rezonans görüntüleme
Kaynakça
- Al-Salama, Z. T. (2021). Metyrapone in Cushing’s Syndrome: A Profile of its Use. Drugs & Therapy Perspectives, 37(9), 393-406.
- Braun, L. T., & Reincke, M. (2020). What is The Role of Medical Therapy in Adrenal-Dependent Cushing’s Syndrome? Best Practice & Research Clinical Endocrinology & Metabolism, 34(3), 101376.
- Castinetti, F. (2023). Pharmacological Treatment of Cushing’s Syndrome. Archives of Medical Research, 102908.
- Daniel, E., & Newell-Price, J. D. (2015). Therapy of Endocrine Disease: Steroidogenesis Enzyme Inhibitors in Cushing’s Syndrome. European Journal of Endocrinology, 172(6), R263- R280.
- Rogóz, Z., Skuza, G., Wójcikowski, J., & Daniel, W. A. (2003). Effects of Combined Treatment with Imipramine and Metyrapone in The Forced Swimming Test in Rats. Behavioral And Pharmacokinetic Studies. Polish journal of pharmacology, 55(6), 993–999.
- Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., Casanueva, F. F., Castinetti, F., Chanson, P., Findling, J., Gadelha, M., Geer, E. B., Giustina, A., Grossman, A., Gurnell, M., Ho, K., … & Biller, B. M. K. (2021). Consensus on Diagnosis and Management of Cushing’s Disease: A Guideline Update. The Lancet. Diabetes & endocrinology, 9(12), 847–875.
- Hakami, O. A., Ahmed, S., & Karavitaki, N. (2021). Epidemiology and Mortality of Cushing’s syndrome. Best Practice & Research Clinical Endocrinology & Metabolism, 35(1), 101521.
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. (2018). Cephalalgia : An International Journal of Headache, 38(1), 1–211.
- Healy, D. G., Harkin, A., Cryan, J. F., Kelly, J. P., & Leonard, B. E. (1999). Metyrapone Displays Antidepressant-Like Properties in Preclinical Paradigms. Psychopharmacology, 145, 303- 308.
- Igaz, P., Tombol, Z., Szabo, P., Liko, I., & Racz, K. (2008). Steroid Biosynthesis Inhibitors in The Therapy of Hypercortisolism: Theory and Practice. Current Medicinal Chemistry, 15(26), 2734-2747.